O-Benzyl-N-Boc-L-Homoserine: Handling & Synthesis Protocol
O-Benzyl-N-Boc-L-Homoserine: Handling & Synthesis Protocol
O-Benzyl-N-(tert-butoxycarbonyl)-L-homoserine is a dual-protected, enantiomerically pure L-amino acid building block widely employed in solution- and solid-phase peptide synthesis, where the Boc group shields the α-amine and the benzyl ether protects the side-chain hydroxyl, enabling orthogonal, stepwise deprotection strategies.
- Chemical Name
- O-Benzyl-N-(tert-butoxycarbonyl)-L-homoserine
- Common Abbreviation
- Boc-L-Hse(Bn)-OH
- SKU / Catalog Number
- B185445
- Protecting Group at α-Amine
- tert-Butoxycarbonyl (Boc), removed by TFA or HCl in dioxane
- Protecting Group at Side-Chain Hydroxyl
- Benzyl ether (OBn), removed by hydrogenolysis (H₂/Pd-C)
- Stereochemistry
- L-configuration (S) at the α-carbon
- Recommended Storage
- Store at 2–8 °C, away from moisture and light, under inert atmosphere if opened
Reagent Overview and Chemical Properties
O-Benzyl-N-(tert-butoxycarbonyl)-L-homoserine (Boc-L-Hse(Bn)-OH; SKU B185445) is a protected derivative of L-homoserine, the non-proteinogenic homo-analogue of L-serine in which the side chain is extended by one methylene unit (–CH₂CH₂OH versus –CH₂OH). The free carboxylic acid is available for coupling reactions, while the two orthogonally removable protecting groups allow selective deprotection under mild conditions without epimerization of the stereocenter.
Key physicochemical characteristics include a chiral α-carbon bearing the L (S) configuration, an acid-labile Boc carbamate on the amine, and a hydrogenolysis-labile benzyl ether on the γ-hydroxyl. The compound is typically obtained as a white to off-white crystalline solid. Its solubility profile favors polar aprotic solvents such as DMF and DMSO, as well as ethyl acetate and dichloromethane; it shows limited solubility in water and non-polar solvents.
Materials, Equipment, and Safety
Materials required:
- Boc-L-Hse(Bn)-OH (B185445)
- Coupling reagents (e.g., HATU, DIC/HOBt, or EDC/HOBt) appropriate for the target peptide assembly strategy
- Deprotection reagents: trifluoroacetic acid (TFA) in DCM (typically 20–50% v/v) for Boc removal; H₂ gas and 10% Pd/C in an appropriate solvent (e.g., MeOH or EtOH) for benzyl ether removal
- Anhydrous solvents: DMF, DCM, THF (store over molecular sieves)
- Standard peptide synthesis glassware or automated synthesizer
- Analytical HPLC system and NMR spectrometer for purity verification
Safety considerations: Handle TFA in a fume hood; it is corrosive and volatile. Conduct hydrogenolysis only in designated hydrogen-safe areas with appropriate pressure equipment and ventilation. Pd/C is a pyrophoric catalyst — allow it to dry under inert gas and dispose of spent catalyst by established procedures. Consult the Safety Data Sheet (SDS) for Boc-L-Hse(Bn)-OH before use. Standard personal protective equipment (lab coat, gloves, safety glasses) must be worn throughout.
Step-by-Step Synthesis and Deprotection Protocol
Step 1 — Verification of reagent quality: Confirm identity and purity of Boc-L-Hse(Bn)-OH by TLC or analytical HPLC before use. Optical rotation or chiral HPLC may be used to confirm enantiopurity if critical.
Step 2 — Dissolution: Dissolve the required quantity of Boc-L-Hse(Bn)-OH in anhydrous DMF or DCM at an appropriate concentration (typically 0.1–0.5 M for solution-phase coupling). Stir gently until fully dissolved; mild warming (≤40 °C) may assist dissolution if needed.
Step 3 — Peptide coupling: Activate the carboxylic acid in situ using a suitable coupling reagent (e.g., 1.1–1.5 equiv HATU with 2–3 equiv DIPEA). Add the activated species to the amine-bearing coupling partner. Monitor reaction progress by Kaiser test (for free amines) or analytical HPLC. Standard coupling times range from 30 minutes to 2 hours depending on substrate reactivity.
Step 4 — Boc deprotection: Treat the Boc-protected intermediate with 20–50% TFA in DCM at room temperature for 15–30 minutes. Remove TFA by evaporation under reduced pressure and co-evaporate with toluene or DCM if needed to ensure complete removal. Neutralize the resulting TFA salt with DIPEA or equivalent base prior to the next coupling step.
Step 5 — Benzyl ether removal: Dissolve the Bn-protected intermediate in MeOH or EtOH. Add catalytic Pd/C (5–10 wt% relative to substrate) under an inert atmosphere. Evacuate the flask and backfill with H₂ gas (balloon or Parr apparatus). Stir at room temperature until complete (typically 1–4 hours; monitor by TLC or HPLC). Filter through Celite to remove catalyst; wash with MeOH. Concentrate the filtrate under reduced pressure to obtain the deprotected product.
Step 6 — Purification and analysis: Purify the product by column chromatography, preparative HPLC, or recrystallization as appropriate. Confirm identity by ¹H NMR, ¹³C NMR, and high-resolution mass spectrometry. Assess enantiomeric purity by chiral HPLC or optical rotation measurement if required.
Troubleshooting and Common Issues
Incomplete coupling: If Kaiser test remains positive after the standard coupling time, re-couple with fresh activation reagent. Ensure the coupling reagent and base are added in correct stoichiometry and that the solvent is sufficiently anhydrous.
Racemization at the α-center: Avoid prolonged activation or strongly basic conditions. Use coupling reagents known for low epimerization risk (e.g., HATU/HOAt, DIC/Oxyma). Keep reaction temperature at or below room temperature during activation steps.
Incomplete Boc removal: Extend TFA treatment time or increase TFA concentration. Ensure the substrate is fully dissolved and that TFA contacts all material. Check by analytical HPLC.
Incomplete benzyl deprotection: Increase catalyst loading, extend reaction time, or replenish H₂. Ensure the substrate is fully dissolved and the catalyst is active (use fresh Pd/C). Poisoning of Pd/C by sulfur-containing impurities can inhibit hydrogenolysis; in such cases, switch to Pd(OH)₂/C.
Unexpected side-chain reactions: Confirm that all reagents are compatible with the homoserine ether linkage. Under forcing acidic conditions, the benzyl ether is stable but the Boc group may be lost; under strongly basic conditions, avoid prolonged exposure to prevent side reactions.
Storage, Stability, and Quality Control
Storage conditions: Store Boc-L-Hse(Bn)-OH (B185445) at 2–8 °C in a tightly sealed container, protected from moisture and light. Once opened, the container should be re-sealed under an inert atmosphere (nitrogen or argon) to prevent hydrolysis of the Boc group. For long-term storage, keeping the compound at −20 °C is advisable.
Stability: The Boc carbamate is susceptible to hydrolysis under acidic aqueous conditions and to thermolysis at elevated temperatures. The benzyl ether is stable to most routine synthetic conditions except hydrogenolysis and strong Lewis or Brønsted acids. Avoid exposure to protic acids, strong nucleophiles, and prolonged moisture.
Quality control checks before use:
- Optical rotation: verify against the known value for the L-enantiomer (specific value should be confirmed against supplier CoA; flag for review)
- TLC: single spot under UV (254 nm) and staining with ninhydrin or KMnO₄
- HPLC purity: ≥98% by area normalization is recommended for synthetic applications
- ¹H NMR: confirm presence of Boc singlet (~1.45 ppm, 9H), benzyl CH₂ (~4.5 ppm, 2H), and ArH signals (~7.3 ppm, 5H) in CDCl₃ or DMSO-d₆
Frequently asked questions
What is the difference between Boc and Fmoc protection strategies when using this building block?
Boc-L-Hse(Bn)-OH is designed for Boc/Bn chemistry, where the Boc group is stepwise removed by TFA and the final benzyl ether and any remaining protections are cleaved in a global deprotection step, typically by HF or strong acid (classic SPPS) or by hydrogenolysis (solution phase). In Fmoc-based SPPS, the amine would instead be Fmoc-protected and the side-chain hydroxyl may use tert-butyl or trityl protection; Boc-L-Hse(Bn)-OH would not be the standard building block for Fmoc protocols. Choose the building block matched to your chosen overall strategy.
Can racemization occur during coupling reactions with Boc-L-Hse(Bn)-OH, and how can it be minimized?
α-Amino acid derivatives with a Boc-protected amine can be susceptible to racemization through oxazolone formation during activation, though the risk is generally lower than for N-acyl amino acids. To minimize epimerization, use coupling reagents with low racemization profiles (e.g., HATU/HOAt or DIC/Oxyma Pure), keep activation times short, maintain low temperatures (0 °C to room temperature), and avoid excess base. Monitor the product's enantiopurity by chiral HPLC or optical rotation when stereochemical integrity is critical.
How should the compound be handled if it has been stored for an extended period?
Before use, allow the sealed container to equilibrate to room temperature to prevent moisture condensation on the cold solid. Open the container under a dry nitrogen or argon atmosphere. Verify the purity and identity by analytical HPLC and ¹H NMR before incorporating the reagent into a synthesis to confirm that no degradation (e.g., Boc loss or hydrolysis) has occurred. If purity is below specification, do not use the material in critical synthetic steps without further purification or replacement.
Is Boc-L-Hse(Bn)-OH compatible with solid-phase peptide synthesis (SPPS) resins?
Yes, Boc-L-Hse(Bn)-OH is compatible with Boc-chemistry SPPS resins such as Merrifield resin or PAM resin. Standard activation and coupling conditions apply. The benzyl ether side-chain protection is stable to the repeated TFA treatments used for Boc removal in Boc-SPPS cycles and is cleaved simultaneously with the peptide–resin linkage during the final HF deprotection/cleavage step in classical Boc-SPPS workflows.
References
- Bodanszky, M.; Bodanszky, A. The Practice of Peptide Synthesis, 2nd ed.; Springer: Berlin, 1994.
- Isidro-Llobet, A.; Álvarez, M.; Albericio, F. Amino Acid-Protecting Groups. Chem. Rev. 2009, 109, 2455–2504. doi:10.1021/cr800323s
- El-Faham, A.; Albericio, F. Peptide Coupling Reagents, More than a Letter Soup. Chem. Rev. 2011, 111, 6557–6602. doi:10.1021/cr100048w
- Merrifield, R. B. Solid Phase Peptide Synthesis. J. Am. Chem. Soc. 1963, 85, 2149–2154. doi:10.1021/ja00897a025
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证（带存储）